Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial

Abstract

In women with GSM, the treatment response 12 weeks after laser application was comparable to that of sham applications. There were no obvious differences for secondary outcomes and no serious adverse events were reported.